Literature DB >> 6111378

Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci.

R A Bakay, A B Harris.   

Abstract

Epileptic and normal Macaca mulatta monkey cortex was investigated using ligand binding techniques. Subpial injections of aluminum hydroxide gel into the left sensorimotor cortex produced stable seizure frequencies over a two year period and resulted in specific biochemical and receptor abnormalities. Pair matched CSF samples comparing epileptic and non-epileptic hemispheres showed a significant decreased GABA concentration over the epileptic side. The epileptic cortex demonstrated markedly reduced GABA receptor binding and diminished tissue GABA concentration and GAD activity. Two patterns of receptor loss were observed: nonspecific local cellular drop out involving multiple neurotransmitter receptors; and distal receptor loss which was specific for the neurotransmitter intervention pattern of the cortex. GABAergic receptor loss was more marked than receptor losses for the other neurotransmitter and was more widespread. Scatchard plot analysis demonstrated that the diminished GABAergic receptors within the focus were due to receptor loss and not affinity changes. Spearman rank correlations showed a significant correlation only between the degree of GABAergic receptor loss or decrease in GAD activity and the seizure frequency. Epilepsy appears to be a multifactoral disorder with multiple neuroreceptor abnormalities, the most notable of which are the destruction of GABAergic neurons and GABA receptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6111378     DOI: 10.1016/0006-8993(81)90539-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

Review 2.  Metabolism and nervous system disease: a challenge for our times. Part II.

Authors:  E Roberts
Journal:  Metab Brain Dis       Date:  1986-06       Impact factor: 3.584

Review 3.  Calcium and epileptogenesis.

Authors:  U Heinemann; B Hamon
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

Review 4.  Glutamate, GABA, and CNS disease: a review.

Authors:  J E Walker
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

5.  Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.

Authors:  Hejun Lu; Richard B Silverman
Journal:  J Med Chem       Date:  2006-12-14       Impact factor: 7.446

Review 6.  [Brain tumors and epilepsy].

Authors:  H Stefan; I Blümcke; M Buchfelder
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

7.  Changes in GABA-immunoreactive cell density during motor focal epilepsy induced by cobalt in the rat.

Authors:  M Esclapez; S Trottier
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

Review 8.  GABA neurons in seizure disorders: a review of immunocytochemical studies.

Authors:  C R Houser
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

9.  Involvement of synaptosomal neurotransmitter amino acids in audiogenic seizure-susceptibility and -severity of Rb mice.

Authors:  S Simler; L Ciesielski; J Clement; A Rastegar; P Mandel
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

10.  The selective inhibition of hippocampal glutamic acid decarboxylase in zinc-induced epileptic seizures.

Authors:  M Itoh; M Ebadi
Journal:  Neurochem Res       Date:  1982-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.